Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Equity Average (2016 - 2025)

Historic Equity Average for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $56.3 million.

  • iBio's Equity Average rose 25577.43% to $56.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.3 million, marking a year-over-year increase of 25577.43%. This contributed to the annual value of $18.1 million for FY2025, which is 136.49% down from last year.
  • Latest data reveals that iBio reported Equity Average of $56.3 million as of Q4 2025, which was up 25577.43% from $35.5 million recorded in Q3 2025.
  • In the past 5 years, iBio's Equity Average ranged from a high of $106.7 million in Q2 2021 and a low of $11.2 million during Q4 2023
  • For the 5-year period, iBio's Equity Average averaged around $45.6 million, with its median value being $28.3 million (2022).
  • Per our database at Business Quant, iBio's Equity Average surged by 607256.33% in 2021 and then plummeted by 7869.61% in 2023.
  • iBio's Equity Average (Quarter) stood at $95.6 million in 2021, then tumbled by 64.85% to $33.6 million in 2022, then tumbled by 66.65% to $11.2 million in 2023, then surged by 41.25% to $15.8 million in 2024, then skyrocketed by 255.77% to $56.3 million in 2025.
  • Its Equity Average was $56.3 million in Q4 2025, compared to $35.5 million in Q3 2025 and $13.1 million in Q2 2025.